The phenolic compounds are known to be neuroprotective exhibiting AChE inhibitory activity and could be one of the main approaches for the treatment of AD (Pratap and Shantaram, 2020b) (Pratap et al., 2021). The gene discussed is ACHE; the disease is Alzheimer disease.